Anakinra might be associated with reductions in both mortality and need for mechanical ventilation in COVID-19 patients

The investigators found in a review article of 4 observational studies involving 184 COVID-19 patients (111 received anakinra and 73 received standard treatment), that administration of anakinra in COVID-19 patients is safe and might be associated with reductions in both mortality and need for mechanical ventilation. Randomized clinical trials are warranted to confirm these findings.

Read more right here:
Anakinra might be associated with reductions in both mortality and need for mechanical ventilation in COVID-19 patients